Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchIndependent Academic Research Groups
Research, Drug Development & ManufacturingPharmaceutical Manufacturing
Research, Drug Development & ManufacturingPharmaceutical ManufacturingPsychedelic-Focused Manufacturers
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

Psilo Scientific Ltd

Canada
1 Trial

Psilo Scientific Ltd is a Health Canada-licensed psilocybin producer and wholly-owned subsidiary of Filament Health Corp (NEO: FH), supplying purified botanical psilocybin (PEX010) to clinical trials including the PSYCHED-PAL palliative care microdosing study; it also licensed PEX010 to Cybin for Phase 2 trials in treatment-resistant depression and alcohol use disorder.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Manufacturing Snapshot

Psychedelic-Focused Manufacturer

Scope & Capabilities

API ProductionExtraction & PurificationRegulatory / CMC Support

Supply Use Cases

Clinical TrialsResearch UsePartner-Only Supply

GxP / Compliance

GMP

Facilities & Access

Licensed supply pathway aligned with Filament Health manufacturing and clinical distribution network.

Manufacturing Details

Supported Substances

Purified botanical psilocybin supply for clinical studies and research programs.

Manufacturing Sources

Filament Technology

https://www.filament.health/technology

Quick Facts

Type
Subsidiary
HQ
Canada
Website
Visit

Collaborated Trials

1
Not yet recruitingII

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Start Date
Compounds
Psilocybin